Department of Neurosurgery, University Hospital, Bonn, Germany.
Department of Clinical Chemistry and Pharmacology, University Hospital, Bonn, Germany.
World Neurosurg. 2019 Sep;129:e538-e544. doi: 10.1016/j.wneu.2019.05.210. Epub 2019 May 30.
Hyponatremia has been frequently observed after aneurysmal subarachnoid hemorrhage (SAH), and some data have suggested a correlation with symptomatic cerebral vasospasm and poor outcomes. The present prospective study investigated sodium and water disturbances after aneurysmal SAH with regard to symptomatic vasospasm and patient outcomes.
Data from all patients with aneurysmal SAH treated in our department during a 2-year period were collected. Daily natriuresis, sodium levels, water balance, and serum and urine osmolality were measured at 4 different points: day 1 of admission or bleeding, day 3, day 7, and day 14-21 or discharge. The clinical parameters (i.e., Hunt and Hess grade, aneurysm location and treatment, onset of vasospasm) were reviewed. The patients' outcome was assessed using the Glasgow outcome score and modified Rankin scale.
A total of 101 patients (70 women; median age, 52 years) were enrolled in the present study. Of these 101 patients, 59.4% had a good grade SAH (Hunt and Hess grade 1-3). The most common aneurysm location was the anterior communicating artery (37%). The results from an electrolyte analysis were available for ≤91 patients at days 1 and 78 at discharge. In 33 patients (32.7%), hyponatremia had been diagnosed at any time point. Hyponatremia was most frequently observed at day 1 and later at days 7-10. A location in the anterior communicating artery resulted in hyponatremia more frequently only at day 1 (P = 0.007). The main causes of hyponatremia were cerebral salt-wasting syndrome (early onset) and syndrome of inappropriate antidiuretic hormone secretion (early and late onset).
Distinguishing early- and late-onset hyponatremia is of major relevance, because different therapeutic approaches are required. Only hyponatremia at discharge resulted in less favorable outcomes.
蛛网膜下腔出血(SAH)后常观察到低钠血症,一些数据表明其与症状性脑血管痉挛和不良预后相关。本前瞻性研究调查了 SAH 后钠和水紊乱与症状性血管痉挛和患者结局的关系。
收集了本部门在 2 年内治疗的所有蛛网膜下腔出血患者的数据。在 4 个不同时间点测量日钠排泄量、钠水平、水平衡、血清和尿液渗透压:入院或出血第 1 天、第 3 天、第 7 天和第 14-21 天或出院。回顾了临床参数(即 Hunt 和 Hess 分级、动脉瘤位置和治疗、血管痉挛发作)。使用格拉斯哥结局评分和改良 Rankin 量表评估患者结局。
本研究共纳入 101 例患者(70 例女性;中位年龄 52 岁)。其中 59.4%的患者为良好分级 SAH(Hunt 和 Hess 分级 1-3)。最常见的动脉瘤位置是前交通动脉(37%)。在≤91 例患者中,有电解质分析结果在第 1 天和出院时第 7 天获得。33 例(32.7%)患者在任何时间点均被诊断为低钠血症。低钠血症最常见于第 1 天,随后在第 7-10 天。前交通动脉部位仅在第 1 天导致低钠血症的发生率更高(P=0.007)。低钠血症的主要原因是脑耗盐综合征(早期发病)和抗利尿激素分泌不当综合征(早期和晚期发病)。
区分早发性和晚发性低钠血症具有重要意义,因为需要不同的治疗方法。只有出院时的低钠血症会导致预后不良。